COST REDUCTION AND BURDEN OF DISEASE IN TERIPARATIDE-TREATED PATIENTS WITH OSTEOPOROSIS AND PREVIOUS FRACTURES: A PAYER'S PERSPECTIVE

被引：0
|
作者：
Akarirmak, U. [1 ]
Emral, R. [2 ]
Gumusel, B. [3 ]
Ketenci, A. [1 ]
Sindel, D. [1 ]
Tokgozoglu, A. M. [2 ]
Tuzun, S. [1 ]
Yavuz, D. G. [4 ]
Ertekin, A. [5 ]
Gurbuz, S. [6 ]
Koral, S. [5 ]
机构：
[1] Istanbul Univ, Cerrahpasa Tip, Istanbul, Turkey
[2] Ankara Univ Tip, Ankara, Turkey
[3] Hacettepe Univ, Ankara, Turkey
[4] Fevzi Cakmak Mah Muhsin, Istanbul, Turkey
[5] Lilly Ilac Ticaret Ltd, Istanbul, Turkey
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1116
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS86
引用
收藏
页码：A239 / A240
页数：2
相关论文
共 50 条
  • [1] Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis
    Chen, Peiqi
    Miller, Paul D.
    Delmas, Pierre D.
    Misurski, Derek A.
    Krege, John H.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (11) : 1785 - 1790
  • [2] Change in bone mineral density (BMD) and fracture risk reduction in teriparatide-treated women with osteoporosis.
    Chen, P
    Miller, PD
    Delmas, PD
    Misurski, DA
    Krege, JH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S56 - S57
  • [3] DISEASE BURDEN OF FRACTURES IN PATIENTS WITH OSTEOPOROSIS IN JAPAN
    Fujiwara, S.
    Umareddy, I
    Jaffe, D.
    Teoh, C.
    Taguchi, Y.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A502 - A502
  • [4] Evaluation of the reduction of the pain and new fractures in patient with severe osteoporosis treated with antiriassorbitivi and teriparatide
    Taglialatela, E.
    Angrisani, C. M. D.
    Biondi, M.
    Margiore, D.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S249 - S249
  • [5] RISK OF NEW FRACTURES OVER 4 YEARS IN PATIENTS TREATED WITH TERIPARATIDE DUE TO OSTEOPOROSIS
    Pons, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S333 - S333
  • [6] The Cost of HIV Disease in Northern Italy: The Payer's Perspective
    Rizzardini, Giuliano
    Restelli, Umberto
    Bonfanti, Paolo
    Porazzi, Emanuele
    Ricci, Elena
    Casartelli, Luca
    Foglia, Emanuela
    Carenzi, Laura
    Citterio, Paola
    Orlando, Giovanna
    Maselli, Carlo
    Croce, Davide
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (03) : 211 - 217
  • [7] Payer addressable burden of Crohn's disease in patients treated with ustekinumab and vedolizumab in the United States
    Ghosh, T.
    Smith, I.
    Fehr, J.
    Davidson, J.
    Fan, T.
    Candela, N.
    Tsang, C.
    Koch, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S461 - S462
  • [8] COST OF ILLNESS OF SICKLE CELL DISEASE IN THE US, PAYER'S PERSPECTIVE: (CRESCENT)
    不详
    [J]. VALUE IN HEALTH, 2021, 24 : S202 - S202
  • [9] Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis
    Nakamura, Toshitaka
    Tsujimoto, Mika
    Hamaya, Etsuro
    Sowa, Hideaki
    Chen, Peiqi
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (03) : 321 - 325
  • [10] Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis
    Toshitaka Nakamura
    Mika Tsujimoto
    Etsuro Hamaya
    Hideaki Sowa
    Peiqi Chen
    [J]. Journal of Bone and Mineral Metabolism, 2012, 30 : 321 - 325
12345